VANCOUVER, British Columbia, Sept. 20, 2017 -- NOVAGOLD RESOURCES INC. (TSX:NG) (NYSE American:NG) will release its third quarter financial results after market close October 3, 2017. The conference call and webcast, to discuss these results, will take place October 4, 2017 at 8:00 am PT (11:00 am ET). The webcast and conference call-in details are provided below.
| Webcast: | www.novagold.com/investors/events/ | |
| North American callers: | 1-855-475-2134 | |
| International callers: | 1-661-378-9964 | |
| Conference ID: | 87572517 | |
The webcast will be archived on NOVAGOLD’s website for one year. For a transcript of the call please email [email protected].
NOVAGOLD Contact:
Mélanie Hennessey
Vice President, Corporate Communications
Erin O’Toole
Senior Stakeholder Relations Specialist
604-669-6227 or 1-866-669-6227


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



